Study shows women undergoing menopause can ward off metabolic syndrome Global review reveals four unmet needs of diabetes care Insulin pumps have most reported problems in FDA database Pharmacologic management of type 2 diabetes New developments in type 2 diabetes care Empagliflozin improves survival in type 2 diabetes patients with established cardiovascular disease Estimated to improve life expectancy by one to 4.5 years according to an analysis of data from a major trial Montreal diabetes prevention clinic said to be first of its kind in Canada Study examines risk of serious adverse events with SGLT2 inhibitors in type 2 diabetes Finds twofold increases in the risk of lower limb amputation and diabetic ketoacidosis 2018 Consolidated Canadian guideline for preventing and managing cardiovascular disease in primary care C-CHANGE guideline combines recommendations from nine Canadian cardiovascular-related guidelines to meet primary care needs Pharmacist pushes for free access to insulin pen needles in Ontario In a quest to get insulin pen needles covered under Ontario’s provincial drug plan, one pharmacist is taking matters into her own hands. Combination therapy safe and effective in older type 2 diabetes patients New study examines 'real-world' safety and efficacy of GLP-1 agonist and SGLT-2 inhibitor combo when used in elderly patients with suboptimal glycemic control Second basal insulin/GLP-1 agonist combo for type 2 diabetes now available Glargine–lixisenatide combo joins degludec–liraglutide combo on Canadian market First Previous 24 25 26 27 28 Next Last
